Seminars in Immunology

Papers
(The TQCC of Seminars in Immunology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Cellular stress and macrophage activation235
Exploiting antifungal immunity in the clinical context179
Editorial Board92
Differential immune responses behind different celiac disease manifestations78
Three’s company: The cooperative signals behind the differentiation of Th9 cells72
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity71
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells68
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity68
Editorial Board62
Pyroptosis modulation by bacterial effector proteins60
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges58
Local and Cell-intrinsic complement: The new player in cancer progression56
Resolving inflammatory links between myocardial infarction and vascular dementia55
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi54
Aging of lymphoid stromal architecture impacts immune responses54
Microbial metabolites and immunotherapy: Basic rationale and clinical indications52
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity50
Immunity to pathogenic fungi in the eye48
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?46
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)45
Pyroptosis: A road to next-generation cancer immunotherapy44
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease44
Pyroptosis and the cellular consequences of gasdermin pores38
The noncanonical inflammasome-induced pyroptosis and septic shock36
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity35
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment35
Interplay between the complement system and other immune pathways in the tumor microenvironment35
Western diet influences on microbiome and carcinogenesis34
Immunity to fungi: Editorial overview33
The evolving biology of cross-presentation33
Autoimmune diabetes and targets for immunomodulation31
Neuroimmune interactions between itch neurons and skin microbes30
Interleukin-1β and cancer immune response29
The paradox of aging: Aging-related shifts in T cell function and metabolism29
Adaptive NK cell response to human cytomegalovirus: Facts and open issues29
TREM2: A new player in the tumor microenvironment28
Specialized pro-resolving mediators as modulators of immune responses27
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases26
Recent developments in C3-targeted complement therapeutics25
Thymus aging and immune reconstitution, progresses and challenges24
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy24
Sialic acid and Siglec receptors in tumor immunity and immunotherapy24
Antigen discovery for the development of cancer immunotherapy24
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases23
Introduction to the Special Issue: Nutrition, microbiota and immunity23
T cell control of SARS-CoV-2: When, which, and where?22
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?22
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic22
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination22
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs22
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity21
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders21
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy21
Targeting the tissue-complosome for curbing inflammatory disease20
Editorial Board20
T cell fate decisions during memory cell generation with aging20
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity20
The glycoimmune landscape in health and disease20
Publisher's note: Welcome Prof. Guido Kroemer19
Natural killer cell responses to human oncogenic γ-herpesvirus infections19
0.15499401092529